On a totally seperate issue, saw a write up in news.com.au yesterday on the old using body immune cells to attack leukemia calls. Trialls in Australia i believe. They stated the t cells are removed and then "reprogrammed" to bind to proteins on the surface of cancer cells so they can recognise and attack them. In some cases complete remission achieved. Having said that of 4 leukemia sufferers tested in oz trial apparently 2 died before end, 1 couldnt be treated fir sime reason and one in complete remission so not stunning except for the person in remission i guess.
It would be good if we could find some similar process to bind to cancer cells with cpp then enter with the myc inhibitor? This immuno therapy seems to be scoring more runs around the world at the moment. I guess that is because currently no one can hit myc.
Apparently the immunotherapy mob are going on to look at breast cancer and others also now and appears promising. Sorry couldnt find the link.
- Forums
- ASX - By Stock
- PYC
- Ann: Operational Update-PYC.AX
PYC
pyc therapeutics limited
Add to My Watchlist
0.40%
!
$1.27

Ann: Operational Update-PYC.AX, page-42
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M |
Open | High | Low | Value | Volume |
$1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 1380 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | 1.265 |
2 | 16380 | 1.260 |
3 | 14380 | 1.255 |
3 | 103380 | 1.250 |
1 | 4000 | 1.225 |
Price($) | Vol. | No. |
---|---|---|
1.285 | 1380 | 1 |
1.290 | 27010 | 3 |
1.295 | 25880 | 2 |
1.300 | 59168 | 4 |
1.325 | 9001 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online